Nine Monthly Results Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Dec'20
Dec'19
Dec'18
Net Sales
34.36
26.40
12.15
9.79
3.24
Other Operating Income
0.00
0.00
0.00
0.00
0.00
Total Operating income
34.36
26.40
12.15
9.79
3.24
Raw Material Cost
24.63
23.05
10.49
7.31
1.78
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
1.61
0.50
0.22
-0.39
0.61
Employee Cost
0.46
0.26
0.26
3.32
0.43
Power Cost
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
0.00
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
Other Expenses
2.52
1.13
0.80
3.32
0.80
Total Expenditure (Excl Depreciation)
29.21
24.94
11.77
13.56
3.63
Operating Profit (PBDIT) excl Other Income
5.15
1.46
0.38
-3.77
-0.39
Other Income
0.85
0.48
0.32
0.09
0.03
Operating Profit (PBDIT)
6.00
1.94
0.70
-3.68
-0.36
Interest
0.22
0.09
0.14
0.27
0.11
Exceptional Items
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
5.78
1.85
0.56
-3.95
-0.47
Depreciation
0.77
0.49
0.24
0.15
0.13
Profit Before Tax
5.05
1.38
0.42
-3.91
-0.59
Tax
1.27
0.35
0.10
-1.03
-0.16
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
Profit After Tax
3.75
1.00
0.32
-2.88
-0.44
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
Net Profit
3.75
1.00
0.32
-2.88
-0.44
Share in Profit of Associates
0.08
0.07
0.02
0.00
0.00
Minority Interest
-0.19
0.01
0.04
0.41
0.06
Other related items
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
3.20
1.06
0.38
-1.49
-0.27
Equity Capital
13.72
12.87
12.87
3.82
3.82
Face Value
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
Diluted Earnings per share
0.88
0.32
0.29
-1.55
-0.22
Operating Profit Margin (Excl OI)
14.99%
5.53%
3.13%
-38.51%
-12.04%
Gross Profit Margin
16.82%
7.01%
4.61%
-40.35%
-14.51%
PAT Margin
10.91%
3.79%
2.63%
-29.42%
-13.58%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2025 is 30.15% vs 117.28% in Dec 2024
Consolidate Net Profit
YoY Growth in nine months ended Dec 2025 is 201.89% vs 178.95% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2025 is 252.74% vs 284.21% in Dec 2024
Interest
YoY Growth in nine months ended Dec 2025 is 144.44% vs -35.71% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2025 has improved from Dec 2024
Compare Nine Monthly Results Of Eiko Lifescience With
Figures in Cr
Consolidate Nine Monthly Results
Change(INR)
Change(%)
Net Sales
34.36
49.32
-14.96
-30.33%
Other Operating Income
0.00
0.00
0.00
Total Operating income
34.36
49.32
-14.96
-30.33%
Raw Material Cost
24.63
40.98
-16.35
-39.90%
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
1.61
-0.95
2.56
269.47%
Employee Cost
0.46
4.61
-4.15
-90.02%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.01
-0.02
-200.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
2.52
11.34
-8.82
-77.78%
Total Expenditure (Excl Depreciation)
29.21
55.99
-26.78
-47.83%
Operating Profit (PBDIT) excl Other Income
5.15
-6.67
11.82
177.21%
Other Income
0.85
13.01
-12.16
-93.47%
Operating Profit (PBDIT)
6.00
6.34
-0.34
-5.36%
Interest
0.22
3.98
-3.76
-94.47%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
5.78
2.36
3.42
144.92%
Depreciation
0.77
2.31
-1.54
-66.67%
Profit Before Tax
5.05
0.05
5.00
10,000.00%
Tax
1.27
0.26
1.01
388.46%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
3.75
-0.21
3.96
1,885.71%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
3.75
-0.21
3.96
1,885.71%
Share in Profit of Associates
0.08
-0.01
0.09
900.00%
Minority Interest
-0.19
0.00
-0.19
Other related items
0.00
0.00
0.00
Consolidated Net Profit
3.20
-0.22
3.42
1,554.55%
Equity Capital
13.72
18.81
-5.09
-27.06%
Face Value
10.00
2.00
0.00
Reserves
0.00
0.00
0.00
Gross Profit Margin
16.82%
4.79%
0.00
12.03%
PAT Margin
10.91%
-0.43%
0.00
11.34%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 34.36 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 30.15% vs 117.28% in Dec 2024
Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 3.20 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 201.89% vs 178.95% in Dec 2024
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.15 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 252.74% vs 284.21% in Dec 2024
Nine Monthly - Interest
Interest 0.22 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 144.44% vs -35.71% in Dec 2024
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.99%
in Dec 2025Figures in %
YoY Growth in nine months ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
